ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cut
Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...
- Latest
- Trending
Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...
Discover the latest whale alerts in major tech stocks like NVIDIA, Apple, and Oracle. Stay updated on significant trades influencing ...
Peru's PM reassures no US resentment over growing Chinese investments as President Boluarte prepares for key meetings in China.
LandBridge aims to raise up to $319M in U.S. IPO to take advantage of a stronger public market, listing 14.5M ...
Ultrium leverages real-time data to address mobility issues, promising new innovations. “We aim to understand and solve problems,” says CEO ...
Former Saint Steve Gleason has tapped into his artistic side and plans to collaborate with his children using digital technology. ...
The Runes protocol could benefit Bitcoin's fee economy, with buyers evaluating projects based on ticker quality. However, the success of ...
Former OpenAI researcher warned of a 50% chance of AI annihilating humanity. NIST faces opposition to hiring AI safety head. ...
Discover the financial insights of Newpark Resources, Inc., a leading player in the Oil & Gas Equipment & Services industry. ...
Mega-cap tech stocks are driving the S&P 500's growth, with majority being rated as buys. Some stocks have buy ratings ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.